Joyce Teng

Publications

• Familial urticaria pigmentosa: report of a family and review of the role of KIT mutations. Fett NM, Teng J, Longley BJ. Am J Dermatopathol. 2013; 35 (1): 113-6
• Dermatofibrosarcoma protuberans in children: an update on the diagnosis and treatment. Kornik RI, Muchard LK, Teng JM. Pediatr Dermatol. 2012 Nov-Dec; 29 (6): 707-13
• Treatment of recalcitrant excessive granulation tissue with photodynamic therapy in an eight-year-old patient with focal dermal hypoplasia syndrome. Liu J, Hsu PT, VanderWielen BA, Teng JM. Pediatr Dermatol. 2012 May-Jun; 29 (3): 324-6
• Effective topical combination therapy for treatment of lichen striatus in children: a case series and review. Youssef SM, Teng JM. J Drugs Dermatol. 2012; 11 (7): 872-5
• Progress towards genetic and pharmacological therapies for keratin genodermatoses: current perspective and future promise. Chamcheu JC, Wood GS, Siddiqui IA, Syed DN, Adhami VM, Teng JM, Mukhtar H. Exp Dermatol. 2012; 21 (7): 481-9
• A case of sclerodermatous graft-versus-host disease responsive to imatinib therapy. Lazar J, Poonawalla T, Teng JM. Pediatr Dermatol. 2011 Mar-Apr; 28 (2): 172-5
• Chemically defined conditions for human iPSC derivation and culture. Chen G, Gulbranson DR, Hou Z, Bolin JM, Ruotti V, Probasco MD, Smuga-Otto K, Howden SE, Diol NR, Propson NE, Wagner R, Lee GO, Antosiewicz-Bourget J, Teng JM, Thomson JA. Nat Methods. 2011; 8 (5): 424-9
• Lipoatrophic panniculitis: case report and review of the literature. Shen LY, Edmonson MB, Williams GP, Gottam CC, Hinshaw MA, Teng JM. Arch Dermatol. 2010; 146 (8): 877-81
• Mohs surgical excision of a granular cell tumor with plexiform features on the arm of a 7-year-old child. Youssef SM, Hinshaw M, Longley BJ, Snow S, Teng JM. Dermatol Surg. 2010; 36 (4): 546-50
• Rapid improvement in digital ischemia and acral contracture in a collodion baby treated with topical tazarotene. Liu RH, Becker B, Gunkel J, Teng J. J Drugs Dermatol. 2010; 9 (6): 713-6
• Topical rapamycin: a novel approach to facial angiofibromas in tuberous sclerosis. Haemel AK, O'Brian AL, Teng JM. Arch Dermatol. 2010; 146 (7): 715-8
• CD2-mediated activation of the Tec-family tyrosine kinase ITK is controlled by proline-rich stretch-4 of the CD2 cytoplasmic tail. King PD, Sadra A, Teng JM, Bell GM, Dupont B. Int Immunol. 1998; 10 (7): 1009-16
• Analysis of CD28 cytoplasmic tail tyrosine residues as regulators and substrates for the protein tyrosine kinases, EMT and LCK. King PD, Sadra A, Teng JM, Xiao-Rong L, Han A, Selvakumar A, August A, Dupont B. J Immunol. 1997; 158 (2): 580-90
• CD28-mediated cytotoxicity by the human leukemic NK cell line YT involves tyrosine phosphorylation, activation of phosphatidylinositol 3-kinase, and protein kinase C. Teng JM, Liu XR, Mills GB, Dupont B. J Immunol. 1996; 156 (9): 3222-32
• Phosphorylation of each of the distal three tyrosines of the CD28 cytoplasmic tail is required for CD28-induced T cell IL-2 secretion. Teng JM, King PD, Sadra A, Liu X, Han A, Selvakumar A, August A, Dupont B. Tissue Antigens. 1996; 48 (4 Pt 1): 255-64
• Both major and minor peptide-binding pockets in HLA-A2 influence the presentation of influenza virus matrix peptide to cytotoxic T lymphocytes. Teng JM, Hogan KT. Mol Immunol. 1994; 31 (6): 459-70
• Residues outside of the HLA-A2 peptide-binding groove can abrogate or enhance recognition of influenza virus matrix peptide pulsed cells by cytotoxic T lymphocytes. Teng JM, Hogan KT. Mol Immunol. 1994; 31 (6): 445-57